| scholarly article | Q13442814 |
| P50 | author | Kevin G. Volpp | Q41536230 |
| Jalpa A Doshi | Q88587274 | ||
| P2093 | author name string | Stephen E Kimmel | |
| Bruce Y Lee | |||
| Jingsan Zhu | |||
| P2860 | cites work | Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 |
| Use of the statins in patients after acute myocardial infarction: does evidence change practice? | Q31931741 | ||
| The effect of incentive-based formularies on prescription-drug utilization and spending | Q35600907 | ||
| The effects of prescription drug cost sharing: a review of the evidence. | Q36305793 | ||
| Methods for evaluation of medication adherence and persistence using automated databases | Q36412470 | ||
| Effect of a medication copayment increase in veterans with schizophrenia. | Q36848929 | ||
| Prescription drug cost sharing: associations with medication and medical utilization and spending and health. | Q36869615 | ||
| Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment | Q42616762 | ||
| Pharmacy benefits and the use of drugs by the chronically ill. | Q42627432 | ||
| Unintended consequences of caps on Medicare drug benefits | Q42687029 | ||
| Comparing the health status of VA and non-VA ambulatory patients: the veterans' health and medical outcomes studies | Q44371560 | ||
| Effect of increased copayments on pharmacy use in the Department of Veterans Affairs | Q45332124 | ||
| Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy. | Q50118718 | ||
| A checklist for medication compliance and persistence studies using retrospective databases. | Q53242661 | ||
| The effect of a Medicaid drug copayment program on the utilization and cost of prescription services | Q70494962 | ||
| Long-term persistence in use of statin therapy in elderly patients | Q74497691 | ||
| A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost | Q74549732 | ||
| Persistence of use of lipid-lowering medications: a cross-national study | Q74586986 | ||
| Discontinuation rates of cholesterol-lowering medications: implications for primary care | Q77938701 | ||
| Impact of statin copayments on adherence and medical care utilization and expenditures | Q79437194 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | veteran | Q193891 |
| P304 | page(s) | 390-397 | |
| P577 | publication date | 2009-01-12 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans | |
| P478 | volume | 119 |
| Q56991525 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice |
| Q89490251 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repre |
| Q34046881 | 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repres |
| Q57300917 | A comparison of medication adherence between subsidized and self-paying patients in Malaysia |
| Q48069420 | A randomized controlled trial of co-payment elimination: the CHORD trial. |
| Q48069419 | A randomized controlled trial of negative co-payments: the CHORD trial |
| Q28540727 | A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and development |
| Q40654411 | ACA-mandated elimination of cost sharing for preventive screening has had limited early impact. |
| Q51178953 | Adherence to nucleos(t)ide analogues for chronic hepatitis B in clinical practice and correlation with virological breakthroughs. |
| Q47553382 | Adherence to the American Diabetes Association retinal screening guidelines for population with diabetes in the United States. |
| Q36788354 | Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer |
| Q37730479 | Alternate Day versus Once Daily Atorvastatin for Primary Prevention of (CHD) in Naïve Patients of Dyslipidemia |
| Q35716882 | An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures. |
| Q28541457 | Association between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: a systematic review |
| Q24632347 | Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer |
| Q34772182 | Association of Medicare Part D low-income cost subsidy program enrollment with increased fill adherence to clopidogrel after coronary stent placement |
| Q46120468 | Association of copayment and statin adherence stratified by socioeconomic status |
| Q37113030 | Assurance-médicaments nationale: Le moment d'aller de l'avant |
| Q53709733 | Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. |
| Q34147461 | Copayment Reductions Generate Greater Medication Adherence In Targeted Patients |
| Q33585275 | Costs and benefits of free medications after myocardial infarction |
| Q37808861 | Deeply discounted medications: Implications of generic prescription drug wars |
| Q45982889 | Demographic and clinical factors associated with referrals and compliance to biopsy of oral and maxillofacial lesions. |
| Q36085521 | Does medication adherence following a copayment increase differ by disease burden? |
| Q58703615 | Effect of Medication Copayment on Adherence and Discontinuation in Medicare Beneficiaries with Type 2 Diabetes: A Retrospective Administrative Claims Database Analysis |
| Q45243866 | Effect of electronic prescription on attainment of cholesterol goals |
| Q48526535 | European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted |
| Q48525600 | European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constitute |
| Q34613417 | From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination |
| Q27691392 | How do we improve patient compliance and adherence to long-term statin therapy? |
| Q40095978 | Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence |
| Q44871003 | Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in Finland. |
| Q33931931 | Impact of prescription benefit coverage limits on sevelamer hydrochloride adherence for patients with ESRD. |
| Q35899865 | Impact of the introduction of generic latanoprost on glaucoma medication adherence |
| Q38068349 | Impediments to adherence to post myocardial infarction medications |
| Q90267685 | Improving Medication Understanding and Adherence Using Principles of Memory and Metacognition: In Press - Policy Insights from Behavioral and Brain Sciences |
| Q38190869 | Intentional non-adherence to medications by older adults |
| Q82680876 | Is Optimal Medical Therapy as Used in the COURAGE Trial Feasible for Widespread Use? |
| Q37530975 | Medication Nonadherence After Lung Transplantation in Adult Recipients |
| Q34748351 | Medication adherence among community-dwelling patients with heart failure |
| Q37606776 | Medicines Compliance and Reimbursement Level in Portugal. |
| Q33873068 | Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice. |
| Q37293254 | Monitoring the use of lipid-lowering medication among persons with newly diagnosed diabetes: a nationwide register-based study |
| Q37112999 | National pharmacare: Time to move forward |
| Q45230929 | Non-adherence to cardiovascular medications |
| Q37642755 | Non-adherence to statin therapy: a major challenge for preventive cardiology |
| Q38030904 | Novel incentive-based approaches to adherence |
| Q96224814 | Older patients and geographic barriers to pharmacy access: When nonadherence translates to an increased use of other components of health care |
| Q37762149 | Overcoming 'resistance' to antiplatelet therapy: targeting the issue of nonadherence |
| Q38154826 | Patient co-payment and adherence to statins: a review and case studies. |
| Q24188009 | Pharmaceutical policies: effects of cap and co-payment on rational use of medicines |
| Q38954355 | Poor adherence to P2Y12 antagonists increased cardiovascular risks in Chinese PCI-treated patients |
| Q37050974 | Potential bias in medication adherence studies of prevalent users |
| Q34663970 | Pricing of new vaccines |
| Q34054964 | Quality of life declines after first ischemic stroke. The Northern Manhattan Study |
| Q38361389 | Societal value of generic medicines beyond cost-saving through reduced prices |
| Q26829072 | The effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysis |
| Q43580735 | The effect of increased travel reimbursement rates on health care utilization in the VA. |
| Q36289295 | The roles of past behavior and health beliefs in predicting medication adherence to a statin regimen |
| Q34953788 | Understanding patients' perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review |
| Q88025020 | [Part II. Combination statin plus fibrate regimens (free and fixed)] |
Search more.